Labcorp adopts molecular loop sars-cov-2 research sequencing panel for large-scale viral surveillance

Newton, mass., june 22, 2021 /prnewswire/ -- molecular loop biosciences, inc. , a company redefining the simplicity of targeted sequencing, announced today that its sars-cov-2 research sequencing panel has been deployed by labcorp (nyse: lh), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples.
LH Ratings Summary
LH Quant Ranking